A pharmaceutical composition for improving glucose tolerance of patients and its application
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- QINGDAO HISER MEDICAL CENT
- Publication Date
- 2016-03-23
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention belongs to the technical field of traditional Chinese medicine, and in particular relates to a pharmaceutical composition for improving glucose tolerance of patients and an application thereof, in particular to a pharmaceutical composition for improving glucose tolerance of patients with impaired glucose tolerance and an application thereof. Background technique
[0002] Impaired glucose tolerance (IGT) is a pre-diabetic lesion. IGT is an intermediate state of glucose metabolism between normal and diabetes. Almost all patients with type II diabetes will go through this stage of impaired glucose tolerance. The intervention of IGT has two aspects of non-drug and drug. Non-pharmaceutical measures include dietary intervention, such as restricting the total calorie and fat content of the diet, restricting alcohol consumption, eating less sugar, and encouraging more coarse grains and fresh vegetables containing trace elements such as chromium a...